Skip to main content

Table 1 Baseline characteristics

From: The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis

  TGs mmol/L (mg/dL)
All < 2.26 (< 200) ≥2.26–≤5.65 (≥200–≤500) > 5.65–≤9.94 (> 500–≤880) > 9.94(> 880) > 11.29(> 1000)
Patients, n 7,119,195 5,914,102 1,111,737 72,665 20,691 15,281
Age, years, mean (SD) 54.23 (18.2) 53.89 (18.02) 56.68 (14.98) 53.82 (13.17) 51.28 (11.78) 50.78 (11.32)
Male, n (%) 3,213,139 (45) 2,582,688 (44) 567,319 (51) 48,032 (66) 15,100 (73) 10,869 (71)
TGs, mg/dL, mean (SD) 112.8 (299.3) 67.2 (57.9) 277.8 (61.2) 678 (95.8) 1429.4 (3122.4) 1672.6 (3907.2)
Baseline acute pancreatitis events, n (%)
 0 7,115,037 (99.94) 5,911,134 (99.95) 1,110,849 (99.92) 72,541 (99.83) 20,513 (99.14) 15,119 (98.94)
 1 3681 (0.05) 2657 (0.04) 778 (0.07) 105 (0.14) 141 (0.68) 127 (0.83)
  ≥ 2 477 (0.01) 311 (0.01) 110 (0.01) 19 (0.03) 37 (0.18) 35 (0.23)
Baseline diabetes mellitus, n (%) 1,006,571 (14.14) 712,726 (12.05) 263,230 (23.68) 24,656 (33.93) 5959 (28.80) 1816 (11.88)
Baseline steatosis of liver, n (%) 63,763 (0.90) 41,656 (0.70) 19,240 (1.73) 2130 (2.93) 737 (3.56) 132 (0.86)
Baseline obesity, n (%) 3,044,051 (42.76) 2,545,273 (43.04) 454,548 (40.89) 32,005 (44.04) 12,225 (59.08) 9622 (62.97)
  1. Abbreviations: SD standard deviation, TG triglyceride